'%2F%3E%3Cpath%20d%3D'M11%205H21M13.5%205V11.6A8.5%208.5%200%201%200%2018.5%2011.6V5'%20fill%3D'none'%20stroke%3D'%23fff'%20stroke-width%3D'3.4'%20stroke-linecap%3D'round'%20stroke-linejoin%3D'round'%2F%3E%3Cpath%20d%3D'M10.6%2019.6L13.9%2021.8L17.6%2018.4L21.4%2020.4'%20fill%3D'none'%20stroke%3D'%23fff'%20stroke-width%3D'2.6'%20stroke-linecap%3D'round'%20stroke-linejoin%3D'round'%2F%3E%3Ccircle%20cx%3D'17.6'%20cy%3D'18.4'%20r%3D'2.6'%20fill%3D'%23fff'%2F%3E%3C%2Fsvg%3E){kind=small}
JHS Svendgaard Laboratories Limited
JHS (NSE) · JHS (BSE 532771) · ISIN INE544H01014 · Personal Care · Est. 2004 · listed 2006 · website
ESM Stage 1 · NSE ESM Stage 1 · BSE
In Q1 FY27 (quarter to 30 June 2026, standalone), revenue was ₹30.38 cr and profit after tax ₹1.09 cr. Revenue was 29.6% higher than in Q1 FY26.
Open the full company file Every section, filings and your notes, in the app.
Quarterly results
| Quarter | Revenue | Profit after tax | EPS (₹) | Filed |
|---|---|---|---|---|
| Q1 FY27 standalone | ₹30.38 cr | ₹1.09 cr | 0.13 | 11 Aug 2026 |
| Q4 FY26 standalone | ₹32.7 cr | −₹3.57 cr | −0.42 | 27 Jul 2026 |
| Q3 FY26 standalone | ₹23.27 cr | ₹0.79 cr | 0.09 | 10 Feb 2026 |
| Q2 FY26 standalone | ₹22.28 cr | −₹0.2 cr | −0.02 | 13 Jul 2026 |
| Q1 FY26 standalone | ₹23.45 cr | ₹1.06 cr | 0.12 | 12 Aug 2025 |
| Q4 FY25 standalone | ₹25.17 cr | −₹6.96 cr | −0.84 | 27 May 2025 |
Balance sheet
| As of | Total equity | Borrowings | Total assets |
|---|---|---|---|
| 31 Mar 2026 standalone | ₹175.08 cr | ₹14.81 cr | ₹215.62 cr |
| 30 Sep 2025 standalone | ₹174.05 cr | ₹9.72 cr | ₹207.3 cr |
| 31 Mar 2025 standalone | ₹173.13 cr | ₹5.14 cr | ₹201.57 cr |
Shareholding
| Promoter | FII | DII | Public |
|---|---|---|---|
| 33.85% | 2.87% | 0.00% | 66.15% |
Latest filings
- Annual Report FY2025-26 (New) 2 September 2026 · NSE
- Annual Report FY2025-26 (New) 2 September 2026 · BSE
- JHS Svendgaard Laboratories Limited has submitted to the Exchange, the Un-Audited financial results for the period ended Jun 30, 2026. 11 August 2026 · NSE
- The Board of Directors approved the Un-Audited Financial Results for the Quarter Ended 30th June, 2026 11 August 2026 · BSE
- The Board of Directors in its meeting held on 11th August, 2026 inter alia Considered and Approved the Un-Audited Financial Results for the Quarter Ended 30th June, 2026 11 August 2026 · BSE
Other companies in Personal Care
- Gillette India Limited
- Honasa Consumer Limited
- Cupid Limited
- Colgate Palmolive (India) Limited
- Dabur India Limited
- Emami Limited
- Godrej Consumer Products Limited
- PARAMOUNT COSMETICS (INDIA) LT
Figures as filed by the company with NSE and BSE; surveillance status from the exchanges' lists. Updated 30 September 2026.
Information and calculation tools by Rachid Asen. Not investment advice or research. Facts from company filings and the exchanges' lists, for information only; not a recommendation to buy, sell or hold. Verify with the exchange.